FDA advisory panel split over Sanofi-Lexicon diabetes drug
By Tamara Mathias and Saumya Joseph (Reuters) – An advisory panel to the U.S. Food and Drug Administration was divided over whether to recommend approval of a treatment for type 1 diabetes developed by Lexicon...
Read More